Lonza May Disappoint Investors With Capsule Business Valuation -- Market Talk

Dow Jones

Mar 09

1034 GMT - Lonza's valuation of its capsule business looks "modestly disappointing," RBC Capital Markets' Charles Weston writes in a note to clients. The Swiss healthcare-business manufacturer said late Friday that it will offload a majority stake in its capsule and health-ingredient division to investment firm Lone Star Funds in a deal that values the business at 2.3 billion Swiss francs. That looks a little under what analysts and investors might have expected, Weston says. "This could be somewhat offset by positive sentiment around the buyback and future optionality for greater proceeds in the future and M&A deployment. RBC has an outperform rating and 670 franc target on Lonza stock; shares lose 2.1% to 493.3 francs. (joshua.kirby@wsj.com; @joshualeokirby)

(END) Dow Jones Newswires

March 09, 2026 06:34 ET (10:34 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2618647931"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618647931\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618647931?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 18:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618647931","market":"sg","top_or_hot":-1,"title":"Lonza May Disappoint Investors With Capsule Business Valuation -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1034 GMT - Lonza's valuation of its capsule business looks \"modestly disappointing,\" RBC Capital Markets' Charles Weston writes in a note to clients. The Swiss healthcare-business manufacturer said late Friday that it will offload a majority stake in its capsule and health-ingredient division to investment firm Lone <a href=\"https://laohu8.com/S/SGU\">Star</a> Funds in a deal that values the business at 2.3 billion Swiss francs. That looks a little under what analysts and investors might have expected, Weston says. \"This could be somewhat offset by positive sentiment around the buyback and future optionality for greater proceeds in the future and M&amp;A deployment. RBC has an outperform rating and 670 franc target on Lonza stock; shares lose 2.1% to 493.3 francs. (joshua.kirby@wsj.com; @joshualeokirby) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 09, 2026 06:34 ET (10:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lonza May Disappoint Investors With Capsule Business Valuation -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLonza May Disappoint Investors With Capsule Business Valuation -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-03-09 18:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1034 GMT - Lonza's valuation of its capsule business looks \"modestly disappointing,\" RBC Capital Markets' Charles Weston writes in a note to clients. The Swiss healthcare-business manufacturer said late Friday that it will offload a majority stake in its capsule and health-ingredient division to investment firm Lone <a href=\"https://laohu8.com/S/SGU\">Star</a> Funds in a deal that values the business at 2.3 billion Swiss francs. That looks a little under what analysts and investors might have expected, Weston says. \"This could be somewhat offset by positive sentiment around the buyback and future optionality for greater proceeds in the future and M&amp;A deployment. RBC has an outperform rating and 670 franc target on Lonza stock; shares lose 2.1% to 493.3 francs. (joshua.kirby@wsj.com; @joshualeokirby) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 09, 2026 06:34 ET (10:34 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ISBC","symbol_name":"投资者银行","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2618647931","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618647931","pubTimestamp":1773052440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1034 GMT - Lonza's valuation of its capsule business looks \"modestly disappointing,\" RBC Capital Markets' Charles Weston writes in a note to clients. The Swiss healthcare-business manufacturer said late Friday that it will offload a majority stake in its capsule and health-ingredient division to investment firm Lone Star Funds in a deal that values the business at 2.3 billion Swiss francs. That looks a little under what analysts and investors might have expected, Weston says. \"This could be somewhat offset by positive sentiment around the buyback and future optionality for greater proceeds in the future and M&A deployment. RBC has an outperform rating and 670 franc target on Lonza stock; shares lose 2.1% to 493.3 francs. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ISBC":"投资者银行","BK4211":"区域性银行"},"translate_title":"龙沙胶囊业务估值可能会让投资者失望——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ISBC":1.5},"content_text":"1034 GMT - Lonza's valuation of its capsule business looks \"modestly disappointing,\" RBC Capital Markets' Charles Weston writes in a note to clients. The Swiss healthcare-business manufacturer said late Friday that it will offload a majority stake in its capsule and health-ingredient division to investment firm Lone Star Funds in a deal that values the business at 2.3 billion Swiss francs. That looks a little under what analysts and investors might have expected, Weston says. \"This could be somewhat offset by positive sentiment around the buyback and future optionality for greater proceeds in the future and M&A deployment. RBC has an outperform rating and 670 franc target on Lonza stock; shares lose 2.1% to 493.3 francs. (joshua.kirby@wsj.com; @joshualeokirby) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 09, 2026 06:34 ET (10:34 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}